Vanderbilt University Medical Center: Arthritis Drug May Treat Immunotherapy-Related Heart Complication
December 23, 2020
December 23, 2020
NASHVILLE, Tennessee, Dec. 23 (TNSJou) -- Vanderbilt University Medical Center issued the following news:
A drug typically prescribed for rheumatoid arthritis may also be effective in treating a rare but potentially deadly heart complication some cancer patients experience after taking immunotherapies, according to a study published in Cancer Discovery and co-led by investigators at Vanderbilt University Medical Center.
The researchers demonstrated that the drug abatace . . .
A drug typically prescribed for rheumatoid arthritis may also be effective in treating a rare but potentially deadly heart complication some cancer patients experience after taking immunotherapies, according to a study published in Cancer Discovery and co-led by investigators at Vanderbilt University Medical Center.
The researchers demonstrated that the drug abatace . . .